Article
End-to-end deep learning versus machine learning for biomarker discovery in cancer genomes
2025-01-07
Abstract excerpt
<h4>Background</h4> Accurate determination of genomic biomarkers from tumor sequencing is fundamental to precision oncology, informing disease classification and treatment decisions. In practice, biomarker inference relies on computational pipelines that often compress high-dimensional mutation data into predefined summaries such as mutational signatures or composite genomic features. While robust and widely adop...
Topics
Open a Topic to create a Post that cites this publication.
Identifiers and source
- Literature Corpus work
- 0a21c5b2-15d4-539f-8fbe-81ba947c9607
- DOI
- 10.1101/2025.01.06.631471
